Kawan Renergy Berhad Reports First Quarter 2025 Earnings
Net income: RM4.93m (up by RM4.93m from 1Q 2024).
EPS: RM0.009.
We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Kawan Renergy Berhad shares are down 8.1% from a week ago.
You should always think about risks. Case in point, we've spotted 3 warning signs for Kawan Renergy Berhad you should be aware of, and 1 of them can't be ignored.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
High Growth Tech Stocks in Australia for June 2025
As the Australian market flirts with fresh intraday records, particularly with the ASX200 hovering around 8,650 points, investor sentiment appears cautiously optimistic despite recent volatility in the tech sector. In this environment, identifying high growth tech stocks requires a keen eye for companies that can navigate market fluctuations and capitalize on emerging opportunities, making them potential standouts amidst broader economic uncertainties. Name Revenue Growth Earnings Growth Growth Rating Gratifii 42.14% 113.99% ★★★★★★ Pro Medicus 22.19% 23.49% ★★★★★★ WiseTech Global 20.15% 25.52% ★★★★★★ Wrkr 57.01% 116.83% ★★★★★★ AVA Risk Group 29.15% 108.15% ★★★★★★ BlinkLab 65.54% 64.35% ★★★★★★ Echo IQ 61.50% 65.86% ★★★★★★ Immutep 70.42% 42.39% ★★★★★☆ Adveritas 52.34% 88.83% ★★★★★★ SiteMinder 19.81% 70.04% ★★★★★☆ Click here to see the full list of 47 stocks from our ASX High Growth Tech and AI Stocks screener. We'll examine a selection from our screener results. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Energy One Limited offers software solutions, outsourced operations, and advisory services for wholesale energy and environmental markets across Australasia and Europe, with a market cap of A$468.08 million. Operations: Energy One Limited generates revenue primarily from its energy software industry segment, amounting to A$55.81 million. The company operates within the wholesale energy, environmental, and carbon trading markets in Australasia and Europe. Energy One, recently added to the S&P/ASX All Ordinaries Index, showcases robust growth dynamics within Australia's tech sector. With a remarkable 273.3% earnings increase over the past year, significantly outpacing the software industry's average of 5.6%, Energy One demonstrates strong market performance and potential for sustained growth. This is further underscored by its forecasted annual earnings growth of 42%, which eclipses the broader Australian market's expectation of 11.6%. However, it is crucial to note significant insider selling in recent months which may warrant cautious optimism among investors. Despite this, with a solid return on equity projected at 15.5% in three years and positive free cash flow status, Energy One stands as a compelling case of a company leveraging high-quality earnings and strategic market positioning to potentially shape future industry standards. Click here to discover the nuances of Energy One with our detailed analytical health report. Review our historical performance report to gain insights into Energy One's's past performance. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Infomedia Ltd is a technology company that develops and supplies electronic parts catalogues, service quoting software, and e-commerce solutions for the automotive industry globally, with a market cap of A$471.74 million. Operations: Infomedia generates revenue primarily through its publishing segment, specifically in periodicals, amounting to A$142.41 million. The company focuses on providing digital solutions for the automotive industry worldwide. Infomedia, navigating the competitive tech landscape in Australia, has demonstrated notable financial agility with a significant 61.3% earnings growth over the past year, outperforming the software industry average of 5.6%. This growth trajectory is supported by an aggressive R&D investment strategy, crucial for maintaining its edge in innovation and service delivery in automotive software solutions. The company's revenue is also on an upward curve at 6.9% annually, surpassing the broader Australian market's growth rate of 5.6%. Despite recent executive changes that saw Joanne Hawkins resign as Company Secretary and Jon Brett step down as Chair due to health reasons, Infomedia's robust forecasted annual earnings growth of 19.9% and a promising return on equity projection of 21.7% position it well for future expansion within this dynamic sector. Navigate through the intricacies of Infomedia with our comprehensive health report here. Evaluate Infomedia's historical performance by accessing our past performance report. Simply Wall St Growth Rating: ★★★★★☆ Overview: SiteMinder Limited develops, markets, and sells online guest acquisition platforms and commerce solutions for accommodation providers globally, with a market cap of A$1.32 billion. Operations: The company's primary revenue stream comes from its software and programming segment, generating A$203.65 million. SiteMinder, a trailblazer in the Australian tech scene, is capitalizing on the global shift towards digital hospitality solutions. With an impressive 19.8% annual revenue growth and a projected earnings surge of 70% per year, the company is strategically investing in R&D to innovate further and stay ahead in the competitive market. This focus on development has led to significant advancements in their platform, enhancing user experience and efficiency for hotel operators worldwide. Despite not yet being profitable, SiteMinder's robust growth metrics and future profitability projections underscore its potential as a key player in transforming how hotels engage with technology. Dive into the specifics of SiteMinder here with our thorough health report. Understand SiteMinder's track record by examining our Past report. Click this link to deep-dive into the 47 companies within our ASX High Growth Tech and AI Stocks screener. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:EOL ASX:IFM and ASX:SDR. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
3 hours ago
- Yahoo
Abbott Laboratories (NYSE:ABT) Partners With Tandem To Develop Dual Sensor Diabetes Solutions
Tandem Diabetes Care, Inc. recently announced a significant collaboration with Abbott Laboratories to integrate Abbott's upcoming dual glucose-ketone sensor with Tandem's insulin delivery systems. This and other collaborations, such as the agreement with Sequel Med Tech, align with Abbott's strategic focus on enhancing diabetes care. Abbott's shares rose 3% over the last quarter, aligning closely with broader market trends, which advanced 13% over the past year. The company's robust product approvals and partnerships, alongside positive market sentiment, likely reinforced investor confidence in Abbott's growth trajectory amid generally favorable market conditions. You should learn about the 1 possible red flag we've spotted with Abbott Laboratories. Find companies with promising cash flow potential yet trading below their fair value. The recent collaboration between Tandem Diabetes Care, Inc. and Abbott Laboratories to integrate Abbott's dual glucose-ketone sensor has the potential to enhance Abbott's market positioning in diabetes care. This partnership, along with other strategic agreements, could support revenue growth in Abbott's Diabetes Care segment, though challenges such as tariffs and VBP program impacts in China remain. Abbott's five-year total return, including share price and dividends, stands at 63.31%, showcasing strong longer-term performance, despite some earnings forecast pressure. In the past year, Abbott's shares have risen above the US Medical Equipment industry, which saw a return of 8.2%. This outperformance over a shorter time horizon indicates that investor confidence remains buoyant. However, the expectation of declining earnings over the next three years, with a 10.1% decrease per year, highlights forecast challenges. This contrasts with a forecasted revenue growth of 6.9% annually, which is slower than the broader US market growth rate of 8.6% per year. The current share price of US$133.06 reflects a modest 5.2% discount to the consensus analyst price target of US$140.41, suggesting a perception of fair valuation compared to expected earnings growth and projected revenue increases. Insights from our recent valuation report point to the potential undervaluation of Abbott Laboratories shares in the market. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:ABT. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Vertiv Holdings Co (NYSE:VRT) Unveils AI-Ready Cooling Architecture For NVIDIA GB300 NVL72 Platform
Vertiv Holdings Co recently introduced an energy-efficient 142kW cooling and power reference architecture for the NVIDIA GB300 NVL72 platform, which aligns with broader trends driving technology innovation in data centers. Over the past quarter, Vertiv's stock price rose by 27%, a significant move partially supported by this product release. This rise contrasted with a more modest market uptick where indices like the S&P 500 and Nasdaq saw less dramatic increases, buoyed by benign inflation data and easing U.S.-China trade tensions. Vertiv's innovative strategies clearly supported its positive stock performance during this period. We've identified 2 possible red flags with Vertiv Holdings Co and understanding the impact should be part of your investment process. The latest GPUs need a type of rare earth metal called Neodymium and there are only 24 companies in the world exploring or producing it. Find the list for free. Vertiv Holdings Co's recent introduction of energy-efficient cooling and power solutions aligns well with its strategic focus on AI and data centers, potentially boosting future revenue and earnings. Over a remarkable three-year period, Vertiv's total shareholder return was very large at 1062.27%, reflecting favorable investor sentiment and strong business execution. Despite posting a compelling annual return, Vertiv shares underperformed the US Electrical industry, which saw a 24% increase over the past year. However, Vertiv has outpaced the broader US market, which returned 12.8% over the same period, underlining its robust performance. The collaboration with NVIDIA is likely to reinforce Vertiv's growth trajectory by catalyzing revenue growth through AI infrastructure projects. Analysts forecast a significant upward trend, with revenues expected to rise to approximately $12.2 billion by 2028. While the company's current share price is US$93.48, it remains below the consensus price target of US$108.14, indicating potential room for upside as the market adjusts to revised forecasts. Gain insights into Vertiv Holdings Co's future direction by reviewing our growth report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:VRT. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
